MOOV: Functional Effects and Impact on Motor Neuronal Activity of Early and Intensive Motrice (Hand and Arm Bimanual Intensive Therapy Including Lower Extremities: HABIT-ILE) Reeducation in Children With Pre-school Bilateral Cerebral Palsy

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT04362800
Collaborator
(none)
36
2
2
7.9
18
2.3

Study Details

Study Description

Brief Summary

One of the urgent priorities in the field of pediatric neuro-rehabilitation is the development of efficient early motor interventions for children with cerebral palsy (CP). Animal studies suggest that early intensive interventions are likely to have a significant impact on the organization of the brain and corticospinal tracts, reducing motor impairments and their medium and long-term consequences in children with cerebral palsy. Although most of the growth, development and cortical organization takes place in the time course of the first 2 years of life, most studies investigating the effectiveness of intensive rehabilitation and associated neurophysiological mechanisms have been conducted in school-aged children (> 6 years). In addition, the vast majority of these studies were conducted in children with unilateral CP, while the bilateral form of the pathology has the highest prevalence. It is therefore a priority to investigate the effectiveness of early interventions on the overall motor function of children with CP, especially in children with bilateral form of CP.

Hand and Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) makes it possible to apply the concepts of structured motor learning and intensive treatment to both the upper limbs and the lower limbs and demonstrated improvements at both levels in school-aged children with unilateral CP and bilateral and then at all three International Classification of Functioning and Disability levels. The principles and content of HABIT-ILE can be applied to pre-school children and this method is promising for early neuro-rehabilitation.

Condition or Disease Intervention/Treatment Phase
  • Other: MRI
  • Other: Electro-Encephalography-High Density
  • Other: 3D and EMG analysis
  • Other: care and classic activities
N/A

Detailed Description

The main objective of this study is to evaluate the effect of 10 days (i.e. 50 hours) of early HABIT-ILE (HABIT-ILE) on the overall motor function of children aged 1 to 4 with bilateral cerebral palsy in comparison to 10 days (50h) of spontaneous overall motor activity including usual rehabilitation (control group).

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
Functional Effects and Impact on Motor Neuronal Activity of Early and Intensive MOtrice (Hand and Arm Bimanual Intensive Therapy Including Lower Extremities: HABIT-ILE) Reeducation in Children With Pre-school Bilateral Cerebral Palsy: a Trial Multicentre Randomized Control With Medico-economic Evaluation
Actual Study Start Date :
Jan 19, 2021
Actual Primary Completion Date :
Sep 17, 2021
Actual Study Completion Date :
Sep 17, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interventional

10 days of intensive and structured motor therapy, 5 hours a day = 50h

Other: MRI
MRI at baseline and J90

Other: Electro-Encephalography-High Density
Electro-Encephalography-High Density (children with unilateral PC only) at baseline and J90

Other: 3D and EMG analysis
3D and EMG analysis at baseline and J90

Other: care and classic activities
physiotherapy and psychomotility. As needed weekly sessions of speech therapist or orthoptist and daily activities of the child.

Placebo Comparator: Control

10 days of care and classic activities

Other: MRI
MRI at baseline and J90

Other: Electro-Encephalography-High Density
Electro-Encephalography-High Density (children with unilateral PC only) at baseline and J90

Other: 3D and EMG analysis
3D and EMG analysis at baseline and J90

Other: care and classic activities
physiotherapy and psychomotility. As needed weekly sessions of speech therapist or orthoptist and daily activities of the child.

Outcome Measures

Primary Outcome Measures

  1. Gross Motor Function Measure (GMFM) [1 hour]

    Measures change in gross motor function over time in children with cerebral palsy. The score range from 0 to 100 as a percentage. 100 is the best outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Months to 59 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Child with bilateral cerebral palsy proven to be spastic or dyskinetic

  • 1 to 4 years old inclusive (12 to 59 months) (age corrected if premature) able to follow instructions and to be able to carry out all the assessments, in accordance with his age

  • Being matched to a child according to age, etiology of CP / classification of motor function (GMFCS)

  • Signature of consent by the two holders of parental authority

Exclusion Criteria:
  • Exceed 4 years and 11 months (59 months) during the internship evaluation period.

  • Uncontrolled epilepsy.

  • History of toxin injection or surgery in the 6 months preceding the study period or scheduled within 3 months (during the study period).

  • Visual or cognitive deficit preventing the child from seeing the games and interacting

  • Usual contraindications to magnetic resonance imaging (MRI) such as metal implants.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Les Capucins Angers France 49000
2 Fondation ILDYS - Site de Ty Yann Brest France 29000

Sponsors and Collaborators

  • University Hospital, Brest

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT04362800
Other Study ID Numbers:
  • MOOV (29BRC20.0046)
First Posted:
Apr 27, 2020
Last Update Posted:
Dec 21, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Brest
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 21, 2021